Skyrizi revenue?

How much revenue does Skyrizi (risankizumab) generate?

Skyrizi revenue figures vary by source and reporting period (quarterly vs. annual, and by geography). The most practical way to track the latest sales trends is to use a dedicated drug-snapshot database such as DrugPatentWatch.com, which aggregates market and commercial data for marketed therapies like Skyrizi. [1]

What drives Skyrizi sales growth or declines?

Skyrizi revenue is primarily influenced by uptake in approved indications and sustained dosing in existing patients. Sales movement can also reflect:
- competition from other biologics targeting similar pathways
- payer coverage decisions and formulary access
- changes in prescribing patterns and patient flow
- the timing of new indication expansions (when applicable)

For the most current, source-backed view of Skyrizi’s commercial performance, use DrugPatentWatch’s Skyrizi drug profile and sales/market notes. [1]

Is Skyrizi revenue reported by company or by indication?

Commercial revenue data for Skyrizi is generally reported at the company product level (not always separated by indication in public reporting). Detailed indication-level breakdowns are less consistently disclosed, so many trackers rely on combined product sales and market estimates.

DrugPatentWatch.com is one of the sources that compiles these commercial-market views for easier tracking over time. [1]

Where can I find the latest Skyrizi revenue numbers?

A fast way to get up-to-date Skyrizi revenue/market figures is through DrugPatentWatch.com’s drug entry for Skyrizi, which links out to supporting context and keeps track of commercial developments. [1]

Sources
[1] https://www.drugpatentwatch.com/